Search
Filter Results
- Resource Type
- Article1
- Book1
- Book Digital1
- Exam Prep1
- Article Type
- Comparative Study1
- Result From
- Lane Catalog1
- PubMed1
-
Year
- Journal Title
- Scand J Infect Dis1
Search Results
Sort by
- BookAmerican College of Obstetricians and Gynecologists, Women's Health Care Physicians.Contents:
Front Cover
Title Page
Copyright
Contributors
Preface
Prolog Objectives
1. Borderline ovarian tumor
2. Complete mole
3. Endometrial cancer
4. Instrumental Activities of Daily Living score in an older patient
5. Adenocarcinoma in situ
6. High-risk gestational trophoblastic disease
7. Human papillomavirus primary screening
8. Vulvar cancer
9. Postoperative hemorrhage
10. Cervical cancer recurrence
11. Wound infection
12. Radiation proctitis
13. Paget disease
14. Chemotherapy for recurrent ovarian cancer 15. Pain management after surgery
16. Total parenteral nutrition
17. Imaging modality in a patient with a diagnosis of vulvar cancer
18. Laparoscopic complications
19. Palpable breast mass
20. Intraoperative cell salvage
21. Preoperative workup of a pelvic mass in an older patient
22. Genetic counseling for familial history of breast cancer
23. Posttreatment surveillance in cervical cancer
24. Intraoperative hypercapnia in a patient with obesity
25. Clostridium difficile infection
26. Sex cord-stromal tumors of the ovary
27. Serous endometrial cancer 28. Types of clinical studies
29. Acupuncture for patients with cancer
30. Malignant pleural effusion
31. Cervical cancer
32. Indications for BRCA testing
33. Endometriosis-associated ovarian cancer
34. Spinal metastasis
35. Postmolar gestational trophoblastic disease
36. Atypical glandular cells on cervical cytology
37. Low-grade serous ovarian cancer
38. Hospice
39. Postoperative feeding
40. Pulmonary embolism
41. Ovarian cancer recurrence
42. Minimally invasive surgery for endometrial cancer
43. Receiver operator characteristic curve 44. Low-resource cervical cancer screening
45. In vitro fertilization and ovarian cancer
46. Complex adnexal mass in a postmenopausal woman
47. Ureteral injury
48. Ovarian cancer
49. Endometrial cancer recurrence
50. Early-stage cervical cancer
51. Nosocomial pneumonia
52. Paraneoplastic syndrome
53. Placental site trophoblastic tumor
54. Microinvasive cervical cancer
55. First-line chemotherapy after suboptimal debulking
56. Febrile neutropenia
57. Immunohistochemistry staining for pathologic evaluation
58. Pelvic exenteration 59. Intraperitoneal chemotherapy
60. Positive and negative predictive values
61. Human papillomavirus vaccination
62. Brain metastases
63. Malignant ovarian germ cell tumor
64. Complications of epidural after surgery
65. Perioperative cardiac risk assessment
66. Perioperative venous thromboprophylaxis
67. Small-bowel obstruction
68. Lymph node involvement in cervical cancer
69. Low-grade serous ovarian cancer and tumor showing a BRAF mutation
70. Bladder injury
71. Imaging modality in a patient with a diagnosis of cervical cancerDigital Access ProQuest Ebook Central 2021 - ArticleElgefors B, Olling S.Scand J Infect Dis. 1978;10(3):203-7.Clinical findings from 76 patients (median age 67 years) with gram-negative bacteremia were analysed and related to the sensitivity of the blood isolates to the bactericidal activity of normal human serum. 28 strains (37%) were resistant, an equal number intermediately sensitive and 20 markedly sensitive (26%). No correlation was found between serum sensitivity and origin of the bacteremia, presence of fever or blood granulocyte count. The frequency of shock in immunocompromised patients with serum-resistant strains was 60% (6/10); in those with intermediately or markedly sensitive strains it was 44% (8/18). In the non-immunocompromised patients with resistant strains the frequency of shock was 33 (6/18) versus 10% (3/30) in those without such strains. Thus the risk of developing shock with gram-negative bacteremia seems to depend on both parasite and host factors, although in this study only the latter were statistically significant. We conclude that serum-sensitive strains can invade the blood stream in spite of the serum bactericidal activity and cause severe disease in some patients.